248 related articles for article (PubMed ID: 7988455)
1. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3.
Stephanou A; Ross R; Handwerger S
Endocrinology; 1994 Dec; 135(6):2651-6. PubMed ID: 7988455
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid and thyroid hormone regulate placental lactogen expression in human trophoblast cells.
Stephanou A; Handwerger S
Endocrinology; 1995 Mar; 136(3):933-8. PubMed ID: 7867602
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 stimulates placental lactogen expression by human trophoblast cells.
Stephanou A; Handwerger S
Endocrinology; 1994 Aug; 135(2):719-23. PubMed ID: 8033820
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
6. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
[TBL] [Abstract][Full Text] [Related]
7. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.
Peng L; Malloy PJ; Feldman D
Mol Endocrinol; 2004 May; 18(5):1109-19. PubMed ID: 14963110
[TBL] [Abstract][Full Text] [Related]
8. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
Uchida M; Ozono K; Pike JW
J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
[TBL] [Abstract][Full Text] [Related]
9. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.
Wu Y; Craig TA; Lutz WH; Kumar R
Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-I stimulates placental lactogen expression by human trophoblast cells.
Handwerger S; Myers S; Richards R; Richardson B; Turzai L; Moeykins C; Meyer T; Anantharamahiah GM
Endocrinology; 1995 Dec; 136(12):5555-60. PubMed ID: 7588308
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
Xie Z; Bikle DD
J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
[TBL] [Abstract][Full Text] [Related]
12. Calbindin-D28k (CaBP28k) identification and regulation by 1,25-dihydroxyvitamin D3 in human choriocarcinoma cell line JEG-3.
Belkacemi L; Züegel U; Steinmeyer A; Dion JP; Lafond J
Mol Cell Endocrinol; 2005 May; 236(1-2):31-41. PubMed ID: 15922086
[TBL] [Abstract][Full Text] [Related]
13. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
14. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
18. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells.
Du H; Daftary GS; Lalwani SI; Taylor HS
Mol Endocrinol; 2005 Sep; 19(9):2222-33. PubMed ID: 15905361
[TBL] [Abstract][Full Text] [Related]
19. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
20. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
